Arterial stiffness: From physiology to clinical implications

High Blood Pressure and Cardiovascular Prevention

Volumn 18, Issue 1, 2011, Pages 1-12

  Milan, Alberto ^a   Tosello, Francesco ^a   Fabbri, Ambra ^a   Vairo, Alessandro ^a   Leone, Dario ^a   Chiarlo, Michela ^a   Covella, Michele ^a   Veglio, Franco ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

arterial hypertension; arterial stiffness; Arterial tree; pulse wave velocity; subclinical target organ damage

Indexed keywords

ALAGEBRIUM; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; BENDROFLUMETHIAZIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CILNIDIPINE; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; EPROSARTAN; GLITAZONE DERIVATIVE; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDAPAMIDE PLUS PERINDOPRIL; LERCANIDIPINE; LOSARTAN; MINERALOCORTICOID ANTAGONIST; NIFEDIPINE; NITRATE; OMAPATRILAT; PERINDOPRIL; RAMIPRIL; SILDENAFIL; SPIRONOLACTONE; TEMOCAPRIL; VALSARTAN;

ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; AORTA FLOW; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; BLOOD PRESSURE REGULATION; BLOOD VESSEL TONE; BLOOD VESSEL WALL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY PULSE; CAROTID FEMORAL PULSE WAVE VELOCITY; COMPARATIVE EFFECTIVENESS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIURETIC THERAPY; DRUG EFFICACY; DYSLIPIDEMIA; ELASTICITY; EXTRACELLULAR MATRIX; GENETIC PREDISPOSITION; HEART FAILURE; HUMAN; HYPERTENSION; LOW DRUG DOSE; METABOLIC SYNDROME X; MORTALITY; PATHOGENESIS; PREDICTIVE VALUE; PRIORITY JOURNAL; PULSE WAVE; REVIEW; STROKE; VASCULAR RESISTANCE;

ARTERIES; BLOOD PRESSURE; HUMANS; HYPERTENSION;

EID: 79955596561     PISSN: 11209879     EISSN: 11791985     Source Type: Journal    
DOI: 10.2165/11588020-000000000-00000     Document Type: Review

References (90)

1. Lawrence C. Physiological apparatus in the Wellcome Museum, 1: the Marey sphygmograph. Med History 1978 Apr; 22 (2): 196-200 (Pubitemid 8317005)
2. Laurent S, Cockcroft J, Van Bortel L, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006 Nov; 27 (21): 2588-605 (Pubitemid 44627304)
3. Pryor WA, Willson R, Riley PA. In memoriam Trevor Frank Slater (1931-1992). Free Radical Biol Med 1992 Oct; 13 (4): 275-9
4. Christen AI, Sanchez RA, Baglivo HP, et al. Non-invasive assessment of systemic elastic behaviour in hypertensive patients: analysis of possible determinants. Med Progress Through Technol 1997; 21 Suppl.: 5-11 (Pubitemid 27500882)
5. Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 2002 Feb 22; 90 (3): 251-62 (Pubitemid 34633925)
6. Kingwell B, Boutouyrie P. Genetic influences on the arterial wall. Clin Exper Pharmacol Physiol 2007 Jul; 34 (7): 652-7 (Pubitemid 46953114)
7. Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 2005 May; 25 (5): 932-43 (Pubitemid 40627836)
8. Sutton-Tyrrell K, Najjar SS, Boudreau RM, et al. Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation 2005 Jun 28; 111 (25): 3384-90 (Pubitemid 40923391)
9. Monnier M. Changes in pulse wave velocity with age in man: a longitudinal series over 20 years. Experientia 1987 Apr 15; 43 (4): 378-81 (Pubitemid 17060929)
10. McEniery CM, Yasmin, Hall IR, et al. Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol 2005 Nov 1; 46 (9): 1753-60 (Pubitemid 41531635)
11. Reiser KM, Amigable MA, Last JA. Nonenzymatic glycation of type I collagen: the effects of aging on preferential glycation sites. J Biol Chem 1992, Dec 5, 267(34), 24207-24216
12. Lakatta EG, Cohen JD, Fleg JL, et al. Hypertension in the elderly: age- and disease-related complications and therapeutic implications. Cardiovasc Drugs Ther 1993 Aug; 7 (4): 643-53 (Pubitemid 23309341)
13. Giannattasio C, Mangoni AA, Failla M, et al. Impaired radial artery compliance in normotensive subjects with familial hypercholesterolemia. Atherosclerosis 1996 Aug 2; 124 (2): 249-60 (Pubitemid 26228011)
14. Peng X, Haldar S, Deshpande S, et al. Wall stiffness suppresses Akt/eNOS and cytoprotection in pulse-perfused endothelium.Hypertension 2003 Feb; 41 (2): 378-81 (Pubitemid 36204918)
15. Dzau VJ. Significance of the vascular renin-angiotensin pathway. Hypertension 1986 Jul; 8 (7): 553-9 (Pubitemid 16066758)
16. Benetos A, Gautier S, Ricard S, et al. Influence of angiotensin- converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients. Circulation 1996 Aug 15; 94 (4): 698-703 (Pubitemid 26289224)
17. Blacher J, Amah G, Girerd X, et al. Association between increased plasma levels of aldosterone and decreased systemic arterial compliance in subjects with essential hypertension. Am J Hypertens 1997 Dec; 10 (12 Pt 1): 1326-34 (Pubitemid 28078735)
18. Park JB, Schiffrin EL. ET(A) receptor antagonist prevents blood pressure elevation and vascular remodeling in aldosterone-infused rats. Hypertension 2001 Jun; 37 (6): 1444-9 (Pubitemid 34225390)
19. Mitchell GF, Hwang SJ, Vasan RS, et al. Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation 2010 Feb 2; 121 (4): 505-11
20. Lacolley P, Challande P, Osborne-Pellegrin M, et al. Genetics and pathophysiology of arterial stiffness. Cardiovasc Res 2009 Mar 1; 81 (4): 637-48
21. Smulyan H, Vardan S, Griffiths A, et al. Forearm arterial distensibility in systolic hypertension. J Am Coll Cardiol 1984 Feb; 3 (2 Pt 1): 387-93 (Pubitemid 14188478)
22. Laurent S, Hayoz D, Trazzi S, et al. Isobaric compliance of the radial artery is increased in patientswith essential hypertension. J Hypertens 1993 Jan; 11 (1): 89-98 (Pubitemid 23130559)
23. Laurent S,Girerd X, Mourad JJ, et al. Elastic modulus of the radial artery wall material is not increased in patients with essential hypertension. Arterioscler Thromb 1994 Jul; 14 (7): 1223-31
24. Laurent S, Boutouyrie P, Lacolley P. Structural and genetic bases of arterial stiffness. Hypertension 2005 Jun; 45 (6): 1050-5 (Pubitemid 40770302)
25. Blacher J, Asmar R, Djane S, et al. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 1999 May; 33 (5): 1111-7 (Pubitemid 29230958)
26. Ting CT, Chen CH, Chang MS, et al. Short- and long-term effects of antihypertensive drugs on arterial reflections, compliance, and impedance. Hypertension 1995 Sep; 26 (3): 524-30
27. Dart AM, Kingwell BA, Gatzka CD, et al. Smaller aortic dimensions do not fully account for the greater pulse pressure in elderly female hypertensives. Hypertension 2008 Apr; 51 (4): 1129-34 (Pubitemid 351398972)
28. Mitchell GF, Lacourciere Y, Ouellet JP, et al. Determinants of elevated pulse pressure in middle-aged and older subjects with uncomplicated systolic hypertension: the role of proximal aortic diameter and the aortic pressureflow relationship. Circulation 2003 Sep 30; 108 (13): 1592-8 (Pubitemid 37187786)
29. McEniery CM, Yasmin, Wallace S, et al. Increased stroke volume and aortic stiffness contribute to isolated systolic hypertension in young adults. Hypertension 2005 Jul; 46 (1): 221-6 (Pubitemid 40946518)
30. Salomaa V, Riley W, Kark JD, et al. Non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes. The ARIC Study. Atherosclerosis Risk in Communities Study. Circulation 1995 Mar 1; 91 (5): 1432-43
31. Townsend RR, Wimmer NJ, Chirinos JA, et al. Aortic PWV in chronic kidney disease: a CRIC ancillary study. Am J Hypertens 2010 Mar; 23 (3): 282-9
32. Abedin M, Tintut Y, Demer LL. Vascular calcification: mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol 2004 Jul; 24 (7): 1161-70 (Pubitemid 38880003)
33. Moe SM, Chen NX. Pathophysiology of vascular calcification in chronic kidney disease. Circ Res 2004 Sep 17; 95 (6): 560-7 (Pubitemid 39274370)
34. Vlachopoulos C, Kosmopoulou F, Panagiotakos D, et al. Smoking and caffeine have a synergistic detrimental effect on aortic stiffness and wave reflections. J Am Coll Cardiol 2004 Nov 2; 44 (9): 1911-7 (Pubitemid 39424095)
35. Danias PG, Tritos NA, Stuber M, et al. Comparison of aortic elasticity determined by cardiovascular magnetic resonance imaging in obese versus lean adults. Am J Cardiol 2003 Jan 15; 91 (2): 195-9 (Pubitemid 36084306)
36. Mahmud A, Feely J. Divergent effect of acute and chronic alcohol on arterial stiffness. Am J Hypertens 2002 Mar; 15 (3): 240-3 (Pubitemid 34226189)
37. Cecelja M, Chowienczyk P. Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension: a systematic review. Hypertension 2009 Dec; 54 (6): 1328-36
38. Jatoi NA, Mahmud A, Bennett K, et al. Assessment of arterial stiffness in hypertension: comparison of oscillometric (Arteriograph), piezoelectronic (Complior) and tonometric (SphygmoCor) techniques. J Hypertens 2009 Nov; 17 (11): 2186-91
39. Rajzer MW, Wojciechowska W, Klocek M, et al. Comparison of aortic pulse wave velocity measured by three techniques: Complior, SphygmoCor and Arteriograph. J Hypertens 2008 Oct; 26 (10): 2001-7
40. Millasseau SC, Stewart AD, Patel SJ, et al. Evaluation of carotid-femoral pulse wave velocity: influence of timing algorithm and heart rate. Hypertension 2005 Feb; 45 (2): 222-6 (Pubitemid 40179964)
41. Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007 Jun; 25 (6): 1105-87 (Pubitemid 46924065)
42. Safar ME. Can antihypertensive treatment reverse large-artery stiffening? Curr Hypertens Rep 2003 Feb; 12 (1): 47-51
43. Nichols WW, O'Rourke M. McDonald's blood flow in arteries: theoretical, experimental and clinical principles. 5th ed. London: Hodder-Arnold, 2005
44. Moore Jr JE, Burki E, Suciu A, et al. A device for subjecting vascular endothelial cells to both fluid shear stress and circumferential cyclic stretch. Ann Biomed Eng 1994 Jul-Aug; 22 (4): 416-22 (Pubitemid 24264089)
45. Guerin AP, Blacher J, Pannier B, et al. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 2001 Feb 20; 103 (7): 987-92 (Pubitemid 32183805)
46. Shoji T, Emoto M, Shinohara K, et al. Diabetes mellitus, aortic stiffness, and cardiovascular mortality in end-stage renal disease. J Am Soc Nephrol 2001 Oct; 12 (10): 2117-24 (Pubitemid 32880348)
47. Meaume S, Benetos A, Henry OF, et al. Aortic pulse wave velocity predicts cardiovascular mortality in subjects >70 years of age. Arterioscler Thromb Vasc Biol 2001 Dec; 21 (12): 2046-50 (Pubitemid 34219760)
48. Mattace-Raso FU, van der Cammen TJ, HofmanA, et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation 2006 Feb 7; 113 (5): 657-63
49. Willum-Hansen T, Staessen JA, Torp-Pedersen C, et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 2006 Feb 7; 113 (5): 664-70
50. Boutouyrie P, Tropeano AI, Asmar R, et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 2002 Jan; 39 (1): 10-5 (Pubitemid 34098081)
51. Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001 May; 37 (5): 1236-41 (Pubitemid 34163575)
52. Laurent S, Katsahian S, Fassot C, et al. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke 2003 May; 34 (5): 1203-6 (Pubitemid 36547514)
53. Cruickshank K, Riste L, Anderson SG, et al. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation 2002 Oct 15; 106 (16): 2085-90 (Pubitemid 35192814)
54. Kingwell BA, Berry KL, Cameron JD, et al. Arterial compliance increases after moderate-intensity cycling. Am J Physiol 1997 Nov; 273 (5 Pt 2): H2186-91
55. Avolio AP, Clyde KM, Beard TC, et al. Improved arterial distensibility in normotensive subjects on a low salt diet. Arteriosclerosis 1986 Mar-Apr; 6 (2): 166-9 (Pubitemid 16024125)
56. Teede HJ, McGrath BP, DeSilva L, et al. Isoflavones reduce arterial stiffness: a placebo-controlled study in men and postmenopausal women. Arterioscler Thromb Vasc Biol 2003 Jun 1; 23 (6): 1066-71 (Pubitemid 36713562)
57. Ahimastos AA, Natoli AK, Lawler A, et al. Ramipril reduces large-artery stiffness in peripheral arterial disease and promotes elastogenic remodeling in cell culture. Hypertension 2005 Jun; 45 (6): 1194-9 (Pubitemid 40770326)
58. London GM, Pannier B, Vicaut E, et al. Antihypertensive effects and arterial haemodynamic alterations during angiotensin converting enzyme inhibition. J Hypertens 1996 Sep; 14 (9): 1139-46 (Pubitemid 26329293)
59. Asmar RG, Benetos A, Darne BM, et al. Converting enzyme inhibition: dissociation between antihypertensive and arterial effects. J Hum Hypertension 1992 Oct; 6 (5): 381-5
60. Suzuki H, Nakamoto H, Okada H, et al. A selective angiotensin receptor antagonist, valsartan, produced regression of left ventricular hypertrophy associated with a reduction of arterial stiffness. Adv Peritoneal Dialysis 2003; 19: 59-66
61. Klemsdal TO, Moan A, Kjeldsen SE. Effects of selective angiotensin II type 1 receptor blockade with losartan on arterial compliance in patients with mild essential hypertension. Blood Press 1999; 8 (4): 214-9 (Pubitemid 30096972)
62. Munakata M, Nagasaki A, Nunokawa T, et al. Effects of valsartan and nifedipine coat-core on systemic arterial stiffness in hypertensive patients. Am J Hypertens 2004 Nov; 17 (11 Pt 1): 1050-5 (Pubitemid 39469329)
63. Mahmud A, Feely J. Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension. Am J Hypertens 2005 Jan; 18 (1): 50-5 (Pubitemid 40187349)
64. Laurent S, Arcaro G, Benetos A, et al. Mechanism of nitrate-induced improvement on arterial compliance depends on vascular territory. JCardiovasc Pharmacol 1992 Apr; 19 (4): 641-9
65. Agabiti-Rosei E, Porteri E, Rizzoni D. Arterial stiffness, hypertension, and rational use of nebivolol. Vasc Health Risk Manage 2009; 5 (1): 353-60
66. Girerd X, Giannattasio C, Moulin C, et al. Regression of radial artery wall hypertrophy and improvement of carotid artery compliance after long-term antihypertensive treatment in elderly patients. J Am Coll Cardiol 1998 Apr; 31 (5): 1064-73 (Pubitemid 28212507)
67. Raison J, Rudnichi A, Safar ME. Effects of atorvastatin on aortic pulse wave velocity in patients with hypertension and hypercholesterolaemia: a preliminary study. J Hum Hypertens 2002 Oct; 16 (10): 705-10 (Pubitemid 35396504)
68. Ferrier KE, Muhlmann MH, Baguet JP, et al. Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension. J Am Coll Cardiol 2002 Mar 20; 39 (6): 1020-5 (Pubitemid 34234125)
69. Harashima K, Hayashi J, Miwa T, et al. Long-term pioglitazone therapy improves arterial stiffness in patients with type 2 diabetes mellitus. Metabol Clin Exper 2009 Jun; 58 (6): 739-45
70. Vlachopoulos C, Hirata K, O'Rourke MF. Effect of sildenafil on arterial stiffness and wave reflection. Vasc Med (Lond) 2003 Nov; 8 (4): 243-8 (Pubitemid 38585138)
71. McNulty M, Mahmud A, Feely J. Advanced glycation end-products and arterial stiffness in hypertension. Am J Hypertens 2007 Mar; 20 (3): 242-7 (Pubitemid 46283356)
72. Hope SA, Hughes AD. Drug effects on the mechanical properties of large arteries in humans. Clin Exper Pharmacol Physiol 2007 Jul; 34 (7): 688-93 (Pubitemid 46953120)
73. Gerdts E, Wachtell K, Omvik P, et al. Left atrial size and risk of major cardiovascular events during antihypertensive treatment: losartan intervention for endpoint reduction in hypertension trial. Hypertension 2007 Feb; 49 (2): 311-6 (Pubitemid 46143006)
74. Williams B, Lacy PS, Thom SM, et al. Differential impact of blood pressurelowering drugs on central aortic pressure and clinical outcomes: principal results of theConduit Artery Function Evaluation (CAFE) study. Circulation 2006 Mar 7; 113 (9): 1213-25
75. Morgan T, Lauri J, Bertram D, et al. Effect of different antihypertensive drug classes on central aortic pressure. Am J Hypertens 2004 Feb; 17 (2): 118-23 (Pubitemid 38125127)
76. Topouchian J, El Feghali R, Pannier B, et al. Arterial stiffness and pharmacological interventions: the TRanscend arterial stiffNess Substudy (TRANS study). Vasc Health Risk Manage 2007; 3 (4): 381-7
77. Verdecchia P, Angeli F, Repaci S, et al. Comparative assessment of angiotensin receptor blockers in different clinical settings. VascHealth Risk Manage 2009; 5: 939-48
78. Griffin KA, Abu-Amarah I, Picken M, et al. Renoprotection by ACE inhibition or aldosterone blockade is blood pressure-dependent. Hypertension 2003 Feb; 41 (2): 201-6 (Pubitemid 36204889)
79. Hirata K, Vlachopoulos C, Adji A, et al. Benefits from angiotensin-converting enzyme inhibitor 'beyond blood pressure lowering': beyond blood pressure or beyond the brachial artery? J Hypertens 2005 Mar; 23 (3): 551-6 (Pubitemid 40684713)
80. Dhakam Z,McEniery CM, Yasmin, et al. Atenolol and eprosartan: differential effects on central blood pressure and aortic pulse wave velocity. Am J Hypertens 2006 Feb; 19 (2): 214-9 (Pubitemid 43350177)
81. Asmar RG, London GM, O'Rourke ME, et al. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/ indapamide combination in hypertensive patient: a comparison with atenolol. Hypertension 2001 Oct; 38 (4): 922-6 (Pubitemid 34258694)
82. Takami T, Shigemasa M. Efficacy of various antihypertensive agents as evaluated by indices of vascular stiffness in elderly hypertensive patients. Hypertens Res 2003 Aug; 26 (8): 609-14 (Pubitemid 37080793)
83. Dhaun N, Macintyre IM, Melville V, et al. Blood pressure-independent reduction in proteinuria and arterial stiffness after acute endothelin-a receptor antagonism in chronic kidney disease. Hypertension 2009 Jul; 54 (1): 113-9
84. Mackenzie IS, McEniery CM, Dhakam Z, et al. Comparison of the effects of antihypertensive agents on central blood pressure and arterial stiffness in isolated systolic hypertension. Hypertension 2009 Aug; 54 (2): 409-13
85. Mitchell GF, Izzo Jr JL, Lacourciere Y, et al. Omapatrilat reduces pulse pressure and proximal aortic stiffness in patients with systolic hypertension: results of the conduit hemodynamics of omapatrilat international research study. Circulation 2002 Jun 25; 105 (25): 2955-61 (Pubitemid 34693826)
86. Mahmud A, Feely J. Effect of angiotensin ii receptor blockade on arterial stiffness: beyond blood pressure reduction.AmJ Hypertens 2002 Dec; 15 (12): 1092-5 (Pubitemid 35397544)
87. Anan F, Takahashi N, Ooie T, et al. Effects of valsartan and perindopril combination therapy on left ventricular hypertrophy and aortic arterial stiffness in patients with essential hypertension. Eur J Clin Pharmacol 2005 Jul; 61 (5-6): 353-9 (Pubitemid 41569309)
88. Topouchian J, Asmar R, Sayegh F, et al. Changes in arterial structure and function under trandolapril-verapamil combination in hypertension. Stroke 1999 May; 30 (5): 1056-64 (Pubitemid 29211627)
89. Lacourciere Y, Beliveau R, Conter HS, et al. Effects of perindopril on elastic and structural properties of large arteries in essential hypertension. Can J Cardiol 2004 Jun; 20 (8): 795-9 (Pubitemid 39089608)
90. Mitchell GF, Dunlap ME, Warnica W, et al. Long-term trandolapril treatment is associated with reduced aortic stiffness: the prevention of events with angiotensin-converting enzyme inhibition hemodynamic substudy. Hypertension 2007 Jun; 49 (6): 1271-7 (Pubitemid 46809368)